Beneficiary Advocates Blast CMS For Shifting Drug Formulary/Cost-Sharing Reviews To States
April 17, 2017
Beneficiary advocates are upset by CMS' move to stop reviewing drug formularies as part of the Qualified Health Plan (QHP) certification process for federally facilitate marketplace states that conduct plan management, arguing that punting to the states could weaken patient protections. The advocates note that CMS initially took on the job because plans were limiting coverage, charging high patient cost-sharing, and discriminating against patients with serious and chronic health conditions. One advocacy group has already requested a meeting with the...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to their next steps following the collapse of their efforts to repeal and replace.